Barrow Neurol Group- Site Number : 840087 — Phoenix, Arizona

Barrow Neurol Group- Site Number : 840087 is a clinical research site located in Phoenix, Arizona, United States 85013.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Barrow Neurol Group- Site Number : 840087 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Glycogen Storage Disease Type II (GSD-II), Pompe Disease (Late-onset), Glycogenesis 2 Acid Maltase Deficiency.

Sponsors: Genzyme, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Barrow Neurol Group- Site Number : 840087?

Barrow Neurol Group- Site Number : 840087 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Barrow Neurol Group- Site Number : 840087 conducted?

Barrow Neurol Group- Site Number : 840087 has 1 clinical trials on record, with 1 currently active. Their work covers Glycogen Storage Disease Type II (GSD-II), Pompe Disease (Late-onset), Glycogenesis 2 Acid Maltase Deficiency.

Is Barrow Neurol Group- Site Number : 840087 accredited by Crixeo Health?

Barrow Neurol Group- Site Number : 840087 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Barrow Neurol Group- Site Number : 840087?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.